Contact Us EN / 中
  • Company
  • People
  • Pipeline
    • Our Pipeline
  • Partnering
    • In-Licensing
  • News & Events
  • careers
  • CONTACT US
    EN / 中
Borderless Innovation
guided byGlobal Intelligence

About Inmagene

Learn more

Our pipeline

Inmagene has a robust and growing pipeline, focused on treating immunological diseases.
Learn more

Clinical Trials

IMG-004 and IMG-007 are completing global phase I studies and IMG-008 is entering Phase I.
Learn more

Partnering

Inmagene has formed strategic partnerships with Affibody AB and HUTCHMED (Nasdaq/AIM: HCM) to develop highly innovative drug candidates.

Inmagene has several assets with strong differentiations available for partnering.

Learn more
News and Events
View all news
Copyright © . Inmagene All rights reserved. 沪ICP备2021011492号-1